Worried about memory problems Back Causes of memory problems Talking to someone about their memory problems Is it getting older or dementia?
You can order up to ten items from this form, which we will send to you in the post. Alzheimer’s Society will cover the cost of up to ten items, and delivery. If you tick more than ten boxes, your ...
Get local dementia statistics by exploring Integrated Care System (ICS) data using our interactive map. Understanding the scale of dementia within an area is paramount for providing high quality local ...
Alzheimer's Society says it’s alarming that nearly two thirds of care workers have not received any dementia training, and a long-term social care workforce strategy is needed. Today, Wednesday 13 ...
If you're living with dementia, find out about technology that can help with different aspects of daily life. There are many different technologies that can help you in your everyday life. This ...
DiADeM is a tool to support GPs in diagnosing dementia for people living with advanced dementia in a care home setting. It has been developed by the Yorkshire and Humber Dementia Strategic Clinical ...
Follow our regional social media accounts and find out what's happening in your local area. As well as following our main Twitter account (@alzheimerssoc) and Facebook page, you can also follow social ...
Worried about memory problems Back Causes of memory problems Talking to someone about their memory problems Is it getting older or dementia?
Sometimes a person with dementia can lose their inhibitions and may behave in ways that others find embarrassing. Sometimes a person with dementia can lose their inhibitions and may behave in ways ...
Alzheimer's Society responds to the Autumn Budget announcement of £600 million in social care funding and what this might mean for people affected by dementia. Tim Baverstock, Head of Local Systems ...
Tim Baverstock, Head of Local Systems Influencing at Alzheimer’s Society, welcomes the development of the CQC’s dementia strategy. The State of Care report shows that dementia cannot, and must not, be ...
The MHRA have approved donanemab for the treatment of Alzheimer’s disease. However, NICE does not recommend use on the NHS for any patients. The Medicines and Healthcare products Regulatory Agency ...